Atrial Cardiomyopathy: Pathophysiology, Diagnostic Approaches, and Prognostic Implications—A Narrative Review
Journal of Clinical Medicine · 15.08.2026 · 15 (16) · 6317
DOI: 10.3390/jcm15166317 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.08.2026. Verfasst von Greta Barauskiene und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cardiology Laboratory, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu av. 15, LT-50162 Kaunas, Lithuania. Die Arbeit nennt 163 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atrial cardiomyopathy (ACM) is defined as any complex of structural, architectural, functional, electrophysiological, and molecular changes affecting the atria that may result in clinically significant health consequences. ACM can be caused by a variety of factors, including age-related changes, valvular or vascular disease, genetic diseases, congestive heart failure, metabolic diseases, cardiovascular disease (CVD) risk factors such as arterial hypertension (AH) or obesity, obstructive sleep apnea, and other infectious or noninfectious diseases predisposing to chronic inflammation. The diagnosis of ACM relies on several modalities, including electrocardiography, echocardiography, cardiac magnetic resonance imaging (MRI), computed tomography (CT), electroanatomical mapping (EAM), genetic studies, and biomarkers, which can detect and characterize structural, mechanical, and electrical atrial dysfunction. These changes often include structural atrial remodeling (fibrosis), abnormal structure of the atrial wall and its components, and contractile and electrical dysfunctions. When assessing aspects of ACM, structural changes in the atria such as left atrium (LA) size and fibrosis; LA architectural changes such as the expression of remodeling; changes in LA mechanics such as echocardiographic stress indices; changes in reservoir function and changes in contraction; biological factors determining changes in biomarkers; possible genetic predispositions and higher expression of certain genes encoding certain proteins; and arrhythmogenic factors associated with a higher risk of atrial fibrillation (AF) and stroke and a worse short- and long-term prognosis are very important. When considering the challenges of diagnosing ACM, it should be noted that without standardized diagnostics, most ACM diagnostic situations remain primarily research tools rather than practical clinical diagnostic methods. This review critically evaluates the evidence and translational gaps in the diagnosis of ACM, synthesizing the emerging role of advanced diagnostics and their clinical and prognostic implications as a key future tool for individual risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Cardiology Laboratory, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu av. 15, LT-50162 Kaunas, Lithuania.
- Medical Academy, Lithuanian University of Health Sciences, A. Mickeviciaus 9, LT-44307 Kaunas, Lithuania.
- Laboratory of Molecular Cardiology, Institute of Cardiology, Lithuanian University of Health Sciences, Sukileliu av. 15, LT-50162 Kaunas, Lithuania.
ORCID-Profile: Sandrita Simonyte
Zitieren
APA
Barauskiene, G., Barauskas, M., Simonyte, S., & Vaskelyte, J. J. (2026). Atrial Cardiomyopathy: Pathophysiology, Diagnostic Approaches, and Prognostic Implications—A Narrative Review. Journal of Clinical Medicine, 15(16), 6317. https://doi.org/10.3390/jcm15166317
Vancouver
Barauskiene G, Barauskas M, Simonyte S, Vaskelyte JJ. Atrial Cardiomyopathy: Pathophysiology, Diagnostic Approaches, and Prognostic Implications—A Narrative Review. Journal of Clinical Medicine. 2026;15(16):6317. doi:10.3390/jcm15166317
BibTeX
@article{Barauskiene2026,
author = {Barauskiene, Greta and Barauskas, Mindaugas and Simonyte, Sandrita and Vaskelyte, Jolanta Justina},
title = {Atrial Cardiomyopathy: Pathophysiology, Diagnostic Approaches, and Prognostic Implications—A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {16},
pages = {6317},
doi = {10.3390/jcm15166317}
}
EUVIMED